Medical News on Cancer

Maligant Transformation In Chronic Leukemia May Be Powered By MiR Loss

Jul 08, 2012

Loss of a particular microRNA in chronic lymphocytic leukemia shuts down normal cell metabolism and turns up alternative mechanisms that enable cancer cells to produce the energy and build the molecules they need to proliferate and invade neighboring tissue. The findings come from a new study led by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G... Read More

Clot-Busting Drugs Delivered Directly To Obstructed Blood Vessels By Novel Nanotherapeutic

Jul 08, 2012

Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University have developed a novel biomimetic strategy that delivers life-saving nanotherapeutics directly to obstructed blood vessels, dissolving blood clots before they cause serious damage or even death... Read More

Fertility Drug Usage And Cancer Risk

Jul 07, 2012

Women using fertility drugs who did not conceive a 10-plus week pregnancy were at a statistically significant reduced risk of breast cancer compared to nonusers; however, women using the drugs who conceived a 10-plus week pregnancy had a statistically significant increased risk of breast cancer compared to unsuccessfully treated women, but a comparable risk to nonusers, accor... Read More

Early Stage Breast Cancer Patients Benefit From Single Dose Radiation At Time Of Surgery

Jul 06, 2012

The NewYork-Presbyterian Hospital/Weill Cornell Medical Center is the first and only hospital in New York City that offers women with early stage breast cancer innovative INTRABEAM radiotherapy, which is administered in a single dose during surgery. Women with early stage breast cancer often undergo a lumpectomy to remove a cancerous tumor... Read More

Neighboring Non-Cancer Cells May Contribute To Drug Resistance In Skin Cancer

Jul 06, 2012

One of cancer's most frightening characteristics is its ability to return after treatment. In the case of many forms of cancer, including the skin cancer known as melanoma, tailored drugs can eradicate cancer cells in the lab, but often produce only partial, temporary responses in patients... Read More

Structured Training In Simulated Environment Improves Surgical Residents' Performance In OR

Jul 06, 2012

New research has shown that surgical residents who received structured training in a simulated environment perform significantly better when they start operating on patients. The results of the study by researchers at St... Read More

Halting The Spread Of Cancer By Following The Genomic Pathways

Jul 06, 2012

As the Genetics Society of America's Model Organism to Human Biology (MOHB): Cancer Genetics Meeting in Washington, D.C. drew to a close, it was clear that the mantra for drug discovery to treat cancers in the post-genomic era is pathways. Pathways are ordered series of actions that occur as cells move from one state, through a series of intermediate states, to a final action... Read More

Unresponsive Aplastic Anemia Patients May Benefit From Eltrombopag

Jul 06, 2012

Eltrombopag, a drug that was designed to stimulate production of platelets from the bone marrow and thereby improve blood clotting, can raise blood cell levels in some people with severe aplastic anemia who have failed all standard therapies. About one-third of aplastic anemia cases do not respond to standard therapy, a combination of immune-suppressing drugs... Read More

'Oncometabolite' Linked To Onset Of Acute Myeloid Leukemia

Jul 06, 2012

A team of international scientists led by principal investigator Dr. Tak Mak at the Princess Margaret Cancer Centre, University Health Network, has identified a causative link between the product of a mutated metabolic enzyme and the onset of acute myeloid leukemia (AML), one of the most common types of leukemia in adults... Read More

Researchers Have Discovered A New Gene Target For Leukemia Therapy

Jul 06, 2012

These findings, slated for the July 26, 2012 print issue of Blood, the journal of the American Society of Hematology, could lead to cellular targets for a patient population that otherwise may not have desirable outcomes and could potentially stop the onset of leukemia before it begins... Read More

Previous Page   Next Page